| HOME >> BIOLOGY >> TECHNOLOGY |
-------------------------------------------------------------------------
Total current liabilities $ 1,659 $ 1,901
Convertible royalty participation units 6,821 6,247
Preferred shares - -
-------------------------------------------------------------------------
Total liabilities $ 8,480 $ 8,148
-------------------------------------------------------------------------
Shareholders' (deficiency) equity
Common shares $ 125,156 $ 125,156
Equity portion of convertible royalty
participation units 4,554 4,554
Contributed surplus 8,334 8,091
Deficit (140,126) (137,482)
-------------------------------------------------------------------------
Total shareholders' (deficiency) equity $ (2,082) $ 319
-------------------------------------------------------------------------
Total liabilities and shareholders'
(deficiency) equity $ 6,398 $ 8,467
-------------------------------------------------------------------------
-------------------------------------------------------------------------
STATEMENTS OF LOSS, COMPREHENSIVE LOSS
AND DEFICIT Three months ended
Unaudited - In Thousands of Canadian dollars July 31,
(except per share amounts) 2008 2007
-----------------------
Revenue
Research and development collaboration - 6
---------
'/>"/>
| SOURCE MIGENIX Inc. Copyright©2008 PR Newswire. All rights reserved |